II. Pathophysiology
- Excessive Vitamin D manifests as Hypercalcemia- Risk of Nephrolithiasis, soft tissue calcification, Renal Injury, cardiovascular injury
 
- Toxicity requires chronic ingestions of large amounts of Vitamin D
- Toxic ingestion Levels- Acute (ingestion >100 fold higher than RDA)- Toddler: >2.5 million units
- Adult: >4.0 million units
 
- Chronic- Child: >2000 units/day
- Adult: >75,000 units/day
 
 
- Acute (ingestion >100 fold higher than RDA)
III. Risk Factors
- See Hypercalcemia
- Primary Hyperparathyroidism
- Sarcoidosis or other Granulomatous conditions
- Cancers associated with Hypercalcemia
IV. Symptoms
- See Hypercalcemia
- Gastrointestinal
- Cardiopulmonary- Hypertension
- Arrhythmias
- Prolonged QRS
- Short QTc
 
- Neurologic
- Metabolic
V. Labs
- See Unknown Ingestion
- 
                          Electrolytes- Including Creatinine and eGFR, Serum Calcium and Serum Phosphorus
- Serum Alkaline Phosphatase normal or low
 
- 
                          Vitamin D (25-HydroxyVitamin D)- May be elevated >80-100 ng/ml
 
- Urinalysis
VI. Diagnostics
- 
                          Electrocardiogram (observe for Hypercalcemia changes)- Short QT Interval
- Prolonged PR Interval (first degree AV Block)
- Wide QRS Complex
- Bradycardia
 
VII. Management
- See Hypercalcemia
- See Unknown Ingestion
- Consider Activated Charcoal for ingestion within prior hour and controlled airway- Indicated for large ingestion (>100 times RDA, 17 rodenticide pellets)
 
- 
                          Intravenous Fluids and intravenous Furosemide- Forced diuresis
 
- Manage Seizures- Benzodiazepines are primary agents
- See Status Epilepticus
 
- Severe, refractory Hypercalcemia- Consider Hemodialysis (with Calcium-free dialysate)
- Consider Prednisone
- Consider Bisphosphonates
 
- Disposition- Minor ingestions may be monitored at home
- Acute Overdose- Monitor for 4 to 6 hours after ingestion
 
- Severe Hypercalcemia or neurologic effects- Hospital monitoring
 
 
VIII. References
- Tomaszeski (2022) Crit Dec Emerg Med 36(1): 28
